Cancer Molecular Diagnostics: Suppliers Market Report 2014
DUBLIN, Feb. 20, 2014 /PRNewswire/ –
Research and Markets
) has announced the addition of the
report to their offering.
Cancer diagnostics is one of the most dynamic medical fields, reflecting efforts to translate new advances in cancer into improved tests and treatments. Increasingly, researchers and clinicians pursue common goals towards more personalised therapies, resulting in greater market complexity, new research and clinical needs and changes in laboratory practices. At the same time, end-users seek more powerful tests and instrumentation, as well as greater versatility and flexibility, to meet their increasingly diverse testing needs. This report presents the findings from a new market study of cancer molecular diagnostics and provides valuable commercial insights to suppliers in this field.
This market study was carried out to provide market information to laboratory suppliers in the molecular cancer diagnostics field. Its findings include:
-- Market growth, marketing and sales opportunities -- End-user current practices and future plans -- Market developments, growth and shrinkage -- Innovation and new product opportunities
This study was conducted through specialist groups of experienced end-users in the molecular cancer diagnistics field and its findings are therefore based on ‘real world’ market data.
The challenges of establishing more powerful cancer diagnostics demand that suppliers and end-users work closely to translate new advances into tests that impact on clinical care. These challenges reflect the complexity of this disease and the needs of end-users to make the most of available technology and understanding, to introduce improved capabilities in their own specialised areas. Forging closer relationship with end-users is therefore essential to driving innovation in this field, and to recognising new opportunities. Biopharm Reports assists suppliers in these key areas.
Our specialised market studies are designed to assist laboratory suppliers to profile current and evolving market opportunities. All of our studies are carried out through specialist groups of experienced researchers and clinicians, and therefore findings are based on ‘real world’ market data. By providing new insights and a better understanding of end-user needs, our studies assist suppliers to sell into these markets, and support their innovation, development and strategic planning.
Cancer Molecular Diagnostics 2014 involved the participation of 596 experienced clinicians and research scientists and profiled current practices, developments, trends and future plans over the next three years, as well as growth, shrinkage and opportunities across key areas of this market. Its findings provide suppliers with a wealth of market information on the current and evolving use of cancer molecular diagnostics.
Key Topics Covered:
2. Study Participants
3. Cancer Types
4. Cancer Diagnostic Techniques
5. Molecule Types
6. Study Samples
7. Circulating Tumour Cells
8. Cancer Stem Cells
9. Molecular Cancer Diagnostic Techniques
10. Cancers Tested using Molecular Diagnostic Techniques
11. Molecular Forms
12. Cancer Molecular Diagnostics Biomarkers
13. Clinical Utilities of Cancer Molecular Biomarkers
14. Multiplex Methods
15. Molecular Cancer Diagnostics Trends
16. Main Suppliers
17. Advantages and Disadvantages of Molecular Cancer Diagnostics
18. Future requirements in Cancer Molecular Diagnostics
19. Replacement of Non-Molecular Cancer Diagnostics
20. Automation in Cancer Molecular Diagnostics
21. Most Tested Cancers
22. Costs of Molecular Diagnostics
For more information visit http://www.researchandmarkets.com/research/sr9sgc/cancer_molecular
Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets